| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $26.9B | — | — | — | — |
| Op. Income | $10.7B | — | — | — | — |
| Gross Margin | 94.3% | — | — | — | — |
| Net Margin | 27.5% | — | — | — | — |
| EPS (Diluted) | $2.48 | — | — | — | — |
| Free Cash Flow | $0 | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $26.9B |
| Cost of Revenue | $1.5B |
| GROSS PROFIT | $25.4B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $14.7B |
| Operating Expenses | $14.7B |
| Cost & Expenses | $16.2B |
| OPERATING INCOME | $10.7B |
| Interest Income | $17.2B |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $10.7B |
| Income Tax Expense | $3.0B |
| Net Income from Continuing Ops | $7.7B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | -$1M |
| NET INCOME | $7.4B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $7.4B |
| D&A | $0 |
| EBIT | $10.7B |
| EBITDA | $10.7B |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $26.9B |
| Cost of Revenue | $1.5B |
| GROSS PROFIT | $25.4B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $14.7B |
| Operating Expenses | $14.7B |
| Cost & Expenses | $16.2B |
| OPERATING INCOME | $10.7B |
| Interest Income | $17.2B |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $10.7B |
| Income Tax Expense | $3.0B |
| Net Income from Continuing Ops | $7.7B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | -$1M |
| NET INCOME | $7.4B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $7.4B |
| D&A | $0 |
| EBIT | $10.7B |
| EBITDA | $10.7B |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $7.4B |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$7.4B |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $0 |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $0 |
| FREE CASH FLOW | $0 |
| Net Change in Cash | -$80.8B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $61.8B |
| Short-Term Investments | $62.5B |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $124.3B |
| PP&E (Net) | $2.9B |
| Goodwill | $0 |
| Intangible Assets | $1.8B |
| Long-Term Investments | $1.0T |
| Tax Assets | $0 |
| Other Non-Current Assets | $75.9B |
| TOTAL NON-CURRENT ASSETS | $1.1T |
| TOTAL ASSETS | $1.2T |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $957.7B |
| TOTAL CURRENT LIABILITIES | $957.7B |
| Long-Term Debt | $198.0B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $17.6B |
| TOTAL NON-CURRENT LIABILITIES | $215.6B |
| TOTAL LIABILITIES | $1.2T |
| Common Stock | $58.1B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $58.1B |
| Minority Interest | $1.5B |
| TOTAL EQUITY | $59.6B |
| TOTAL LIABILITIES & EQUITY | $1.2T |
| Total Debt | $198.0B |
| Net Debt | $136.1B |
